Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance and PK of 14C-Tipranavir/Ritonavir in Healthy Males
NCT02253797Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jul 2003
- Primary completion
- Jul 2003
- Modality
- Small Molecules
01
Overview
Phase 1, open-label, single-arm trial of tipranavir in human immunodeficiency virus infection (HIV), sponsored by Boehringer Ingelheim. Primary endpoints: Radioactive levels of 14C-Tipranavir in plasma and blood, Radioactive erythrocyte-plasma partition ratio and 8 more. Started Jul 2003; status: completed.
02
Drugs
tipranavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02253797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02253797.